The overall surface disinfectants market is projected to reach USD 789.1 million, at a CAGR of 8.3%
Surface disinfectants are used to prevent microbial cross-contamination and transmission of microbial infections through surfaces in hospitals, pathology labs, and other patient-related areas. The in-house application segment accounted for the largest share of the market.
Growth in the number of surgical procedures drives the global surface disinfectants market
Globally, the number of surgeries has increased over the last decade majorly due to the increasing prevalence of chronic diseases and growth in the geriatric population. According to the Healthcare Cost and Utilization Project (HCUP), in 2012, a total of 9.7 million procedures were performed in inpatient hospital settings and 9.3 million in outpatient hospital settings in the U.S.
The volume of endoscopic minimally invasive surgeries has witnessed a steady growth over the last decade. According to the CDC, in 2013, a total of 1.1 million small intestine endoscopic surgeries (with or without biopsy) and 499,000 large intestine endoscopic surgeries (with or without biopsy) were performed in the U.S.
Geographical Analysis for surface disinfectants market:
the global market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, however, the Asian region is expected to witness the highest growth during the forecast period.
The presence of emerging economies like China and India; large population; growth in the number of hospitals, and increasing awareness about infection control in the region are some of the key factors driving the high growth of this regional segment.
Major key Players in surface disinfectants market:
3M Company (US), Cantel Medical Corporation (US), Johnson & Johnson (US), Procter & Gamble (US), Reckitt Benckiser Group plc. (UK), the Clorox Company (US), Sealed Air Corporation (US). Steris Corporation (US), and Ecolab (US) are the top players in this market.
The Biobanking Market is expected to reach USD 2.69 Billion by 2022 from USD 1.85 Billion in 2017, at a CAGR of 7.8%.
The base year for this study is 2016. The Biobanking segment is estimated to account for the largest share of the market in 2017. This is primarily attributed to the increasing number of biobanks and rising number of biosamples around the world, due to which the demand for equipment remains high.
The equipment segment is expected to dominate the market in 2017
By-product and service, the Biobanking Market have segmented into equipment, consumables, services, and software. The equipment segment is expected to dominate the global Biobanking Market in 2017. Rising number of biobanks and the increasing number of biospecimens are factors increasing the demand for biobanking equipment.
Blood products are estimated to command the largest market share in 2017
The Biobanking Market is segmented by sample type into blood products, human tissues, nucleic acids, human waste products, cell lines, and biological fluids. In 2017, the blood products segment is expected to account for the largest share of the biobanking market, by sample type. Rising incidence of blood disorders and the increasing demand for various types of blood products across the globe are driving the growth of this segment.
North America is expected to account for the largest share of the market in 2017
Based on region, the Biobanking Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the Biobanking Market in 2017, this is attributed to factors like increasing research activities in regenerative medicine, cell and gene therapy; growing interest in personalized medicine and biomarker discovery; increasing number of biotechnology and pharmaceutical companies; and rising investments in genomics and proteomics research in the region as compared to other regions.
The overall global prefilled syringes market expected to reach $6.36 billion, at a CAGR of 10.1%
Factors driving the growth of this market include technological advancements in prefilled syringes, the high prevalence of chronic diseases, the presence of a large patient population base, rising adoption of self-injection devices, and implementation of needlestick legislation.
In addition, initiatives undertaken by leading market players (such as Gerresheimer AG, SCHOTT AG, and Becton, Dickinson and Company) to establish production facilities in both mature and developing markets have further added to the growth prospects of this market. However, lack of safety features in prefilled syringes and product recalls are expected to limit the growth of this market in the coming years.
Geographical Segmentation of Prefilled Syringes Market:
The market is segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World.
The increasing demand for self-administered treatments and high penetration of self-injection devices, the growing aging population, increasing prevalence of diabetes, and huge patient population is the major factors driving market growth in the region.
Europe is estimated to dominate the global market. Factors such as the rising prevalence of chronic diseases, growth in the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, rising aging population, and high adoption of self-injection devices are driving the growth in the European market. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period.
key players operating in the prefilled syringes market:
Becton, Dickinson and Company (U.S.), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), and MedPro Inc. (U.S.)
The Medical Supplies Market by type is expected to reach USD 136.63 Billion, at a CAGR of 6.8%
Research Methodology:
Top-down and bottom-up approaches are used to estimate and validate the size of the market and the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by type, application, and end user) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
The increasing patient pool for renal diseases is the key driver for the global dialysis supplies market
According to Baxter International, Inc. (U.S.), 3.6 million dialysis and transplanted patients were reported in 2015; this is expected to reach over 4.6 million by 2020. In addition, in the U.S. alone, the number of ESRD cases is expected to reach 785,000 by 2020, due to the addition of ~151,000 patients per year, an increase of 60% as compared to 2005 [Source: The United States Renal Data System]. In addition, the increasing incidences of diabetes and hypertension; rising geriatric population; and increasing adoption of dialysis procedures over kidney transplantations are also supporting the growth of this market.
Browse and in-depth TOC on “Medical Supplies Market”
Growth in the medical supplies market is primarily driven by the increasing prevalence of chronic and infectious diseases, rising number of surgeries, growing geriatric population, and rising number of hospital-acquired infections (HAIs). However, strict and mandate regulatory requirements for the approval of medical supplies and rising number of product recalls are expected to hinder the growth of this market.
Medical supplies application in Urology, Wound Care, Anesthesia and Sterilization drives the growth of medical supplies market
Urology is an important application segment in the medical supplies industry and has witnessed significant growth in recent years owing to the increasing incidence of kidney and urological conditions, and the rising geriatric population. The prevalence of urological and kidney diseases, such as chronic kidney disease (CKD), end-stage renal disease (ESRD), urinary tract infection (UTI), urinary stones, benign prostate hyperplasia (BPH), kidney cancer, and bladder cancer, is increasing across the globe. According to the Scottish Kidney Federation, over 500 million people across the globe suffer from some form of kidney disease.
The key players in the Medical Supplies Market by type include Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), Cardinal Health, Inc. (U.S.), Halyard Health, Inc. (U.S.), Johnson & Johnson (U.S.), Thermo Fisher Scientific Inc. (U.S.), Boston Scientific Corporation (U.S.), Baxter International Inc. (U.S.) and 3M Company (U.S.).
The Global Viral Inactivation Market expected to grow at a CAGR of 12.3% to reach $573.0 million
The Report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global Viral Inactivation Market along with the estimates and forecasts of the revenue and market share analysis.
By method, the market is divided into the solvent detergent method, pasteurization, and other methods. Other viral inactivation method includes low pH, microwave heating, irradiation, and high-energy light. Of these, the solvent detergent method segment accounted for the largest share of the global Viral Inactivation Market.
The application segments included in this report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Of these, the vaccines and therapeutics application hold the highest share.
Browse and in-depth TOC on “Viral Inactivation Market”
72 — Tables
70 — Figures
154 — Pages
By end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users. Other end user segment primarily includes cell banks, small cell culture laboratories and consultants, microbiology laboratories, immunology laboratories, molecular laboratories, animal facilities, toxicology laboratories, and media/sera manufacturers.
The product segments included in the report are kits and reagents, services, and viral inactivation systems and accessories.
Rapidly increasing pharmaceutical and biotechnology industries and the increasing number of new biologics products launched will be the two most important growth drivers for this market in the forecasted period. A strong pharmaceutical product pipeline will aid the growth of the pharmaceutical and biotechnology industry, which is an important end-user of viral inactivation products.
Geographic Analysis for Viral Inactivation Market:
The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). The North America segment is further divided into Canada and the U.S. Asia segment is further divided into China, Japan, India, and Rest of Asia.
Clean Cells (France), Charles River Laboratories International, Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Parker Hannifin (U.S.), Rad Source Technologies (U.S.), Sartorius AG (Germany), SGS S.A. (Switzerland), Texcell, Inc. (France), Viral Inactivated Plasma Systems SA (Switzerland), and WuXi PharmaTech (Cayman) Inc. (China).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1–888–600–6441 Email: sales@marketsandmarkets.com
The North Africa critical care equipment market is expected to reach $2.61 billion, at a CAGR of 8.0%
Continuous technological advancements in critical care devices, increasing government support, growing private sector investments in the healthcare industry, and increasing patient population base are key factors fuelling the growth of the North Africa Critical Care Equipment Market.
Market Segmentation For Critical Care Equipment Market:
On the basis of products, the Asia critical care equipment market is divided into three segments, namely, patient monitors, ventilators, and infusion pumps. The patient monitors segment is expected to grow at the highest CAGR in the next five years, owing to the increasing patient population base and the high adoption of advanced patient monitoring devices by big hospitals and clinics in the emerging nations.
Geographical Analysis For Critical Care Equipment Market:
The global market is classified into Asia (excluding India), India, and the Middle East and North Africa.
The Critical Care Equipment Market is estimated to be dominated by Asia. Rising demand for remote patient monitoring, high adoption rate of technologically advanced critical care devices, and increasing patient population base are contributing to the large share of the Asian Critical Care Equipment Market.
The Indian market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as growing government support, increasing private sector investment, rising geriatric population, growing incidence and prevalence of respiratory and chronic diseases, and developing healthcare infrastructure are propelling the growth of the Indian critical care equipment market.
Major Key Players In the Critical Care Equipment Market:
Koninklijke Philips N.V. (Netherlands), General Electric Company (U.S.), Medtronic plc (U.S.), Drägerwerk AG & Co. KGaA (Germany), Skanray Technologies Pvt. Ltd. (India), Maquet Holding B.V. & Co. KG. (Germany), BPL Medical Technologies Ltd (India), B. Braun Melsungen AG (Germany), Akas Medical (India), Smiths Medical (U.S.), Nihon Kohden Corporation (Japan)
Read More in Detail About Critical Care Equipment Market:
[286 Pages Report] The global Metabolomics Market is expected to reach USD 2,386.4 million by 2021 from USD 1,209.4 million in 2016, at a CAGR of 14.6% during the forecast period.
Metabolomics Market is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples.
Metabolomics Market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.
Geographic Analysis:
Further country-wise breakdown of the Rest of Asia-Pacific Metabolomics Market into South Korea, Australia, New Zealand, and others
Further country-wise breakdown of the Latin American Metabolomics Market into Brazil, Argentina, and Rest of Latin America
Key Questions Answered In This Research Report:
Metabolomics helps identify the type and number of compounds analyzed by making use of several complementary analytical methods and what would be the future of metabolomics instruments in the upcoming years?
How growing demand for personalized medicine and other factors would change the future of Metabolomics Market?
To define, describe, and forecast the global Metabolomics Market on the basis of product & service, application, indication, and region
To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the Metabolomics Market with respect to North America, Europe, Asia- Pacific, Latin America, and the Middle East & Africa
Growing Demand for Personalized Medicine Drive the Metabolomics Market;
The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time.
Such developments are opening new opportunities for the utilization of metabolomics in the development of personalized and precision medicine. Considering significant developments in the field of metabolomics, coupled with the increasing focus of industry participants to leverage the advantages of metabolomics approaches in the development of personalized medicine, the market is expected to witness significant growth in the coming years.
The increasing use of co-processed excipients to improve the dissolution, bioavailability, and solubility of recently developed active pharmaceutical ingredients (APIs), rapid growth in the generics market due to the patent expiration of many blockbuster drugs and increasing development of orally disintegrating tablets (ODT) are expected to propel the growth of this market. The global Sugar-Based Excipients Market is segmented on the basis of product, type, functionality, formulation, and region.
Geographically, the global Sugar-Based Excipients Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, Europe commanded a major share of the global market. Europe’s largest share is primarily attributed to the increasing investments in drug development, increasing the production of generic drugs, and favorable government initiatives in the region. North America, represents the second largest market for sugar excipients.
Factors such as the presence of a large number of global pharmaceutical companies and increasing demand of generic drugs due to patent expiration of blockbuster drugs are majorly contributing to the growth of the market in this region. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the significant growth in the regional healthcare market as well as the pharmaceutical industry, growing scientific base and capability, and favorable government policies, and low-cost manufacturing advantages in this region.
The Medical Supplies Market by type is expected to reach USD 136.63 Billion, at a CAGR of 6.8%
The Research Report on Medical Supplies Market by type provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the global Medical Supplies Market along with the estimates and forecasts of the revenue and market share analysis.
The major factors driving the growth of this market are the rising geriatric population, increasing incidence of various diseases, and the rising number of surgeries.
This report segments the Medical Supplies Market by type on the basis of type, application, end user, and region.
Based on the type, the market is segmented into diagnostic supplies, dialysis consumables, wound care consumables, inhalation products, radiology consumables, infection control supplies, infusion products, intubation and ventilation supplies, personal protective equipment (PPE), hypodermic products, sterilization consumables, and other supplies.
Browse and in-depth TOC on “Medical Supplies Market”
Based on application, the market is segmented into urology, wound care, radiology, anesthesia, sterilization, cardiology, ophthalmology, and other applications. The anesthesia segment is expected to register the highest growth during the forecast period. The high growth in this segment is attributed to the increasing number of surgical procedures being performed across the globe and the rising incidence of respiratory diseases.
Based on end user, the market is segmented into hospitals, clinics, assisted living centers and nursing homes, ambulatory surgery centers (ASCs), and other end users. The hospitals segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing investment in healthcare systems, growing prevalence of HAIs, and high incidence of chronic diseases across the globe.
On the basis of region, the Medical Supplies Market by type is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is projected to be the fastest-growing region in the forecast period, owing to factors such as the rising geriatric population, increasing incidence of various diseases, growing medical tourism industry, and improving healthcare infrastructure.
The key players in the Medical Supplies Market by type include Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Becton, Dickinson and Company (U.S.), Cardinal Health, Inc. (U.S.), Halyard Health, Inc. (U.S.), Johnson & Johnson (U.S.), Thermo Fisher Scientific Inc. (U.S.), Boston Scientific Corporation (U.S.), Baxter International Inc. (U.S.) and 3M Company (U.S.).
